NeuroFinance Human Stress Trial During Financial and Informational Volatility

Part of paid clinical trials in New York, New York.

Sponsor
Truway Health, Inc.
Study ID
NCT07622589
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Anxiety
  • Autonomic Nervous System Dysfunction
  • Behavioral Health
  • Burnout Syndrome
  • Cognitive Fatigue
  • Emotional Stress
  • Financial Stress
  • Heart Rate Variability
  • Insomnia
  • Neurobehavioral Manifestations
  • Occupational Stress
  • Psychological Stress
  • Sleep Disturbance

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Wearable Physiologic Monitoring Platform — DEVICE
    Commercially available wearable physiologic monitoring devices and digital health technologies will be used to collect continuous or intermittent biometric, cardiovascular, autonomic nervous system, behavioral, and sleep-related data during exposure to financial market volatility, economic uncertainty, and information-driven stress environments. Monitoring technologies may include: wearable ECG devices, heart rate variability (HRV) monitors, blood pressure monitoring systems, sleep tracking devices, galvanic skin response sensors, activity monitoring wearables, voice analysis systems, and optional EEG-enabled wearable technologies. Data generated from these systems will be integrated with artificial intelligence and machine learning-based analytics platforms for evaluation of physiologic stress responses and digital biomarker forecasting.

Study Details

The NeuroFinance Human Stress Trial (NFHST-2026-001) is a decentralized observational clinical study designed to evaluate how financial market volatility, economic uncertainty, digital media exposure, and information-driven stress environments affect human physiologic and behavioral health. Participants will undergo remote monitoring using wearable biosensors, cardiovascular telemetry devices, sleep tracking systems, heart rate variability monitoring, and behavioral analytics platforms. The study will use artificial intelligence and machine learning systems to analyze relationships between external financial and informational events and biologic stress responses, including autonomic nervous system activity, sleep disruption, cardiovascular strain, emotional resilience, and inflammatory signaling. The goal of the study is to develop predictive digital biomarkers and AI-assisted forecasting systems capable of identifying stress-related physiologic deterioration before clinical manifestation.

Key Dates

Start date
Jul 15, 2026
Status verified
May 2026
Primary completion
Dec 31, 2028
Completion
Jun 30, 2029

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: Retail Investors / Active Traders Cohort
    Participants actively engaged in retail equity, options, futures, cryptocurrency, or other financial trading activities who are exposed to frequent market volatility and information-driven financial stress environments.
  • Arm: Financial Professionals Cohort
    Participants employed in financial services, institutional trading, investment banking, hedge funds, private equity, fintech, wealth management, or related high-stress financial occupations.
  • Arm: General Population Control Cohort
    Participants from the general population with varying levels of financial market exposure serving as a comparative baseline cohort for physiologic and behavioral stress-response analysis.
  • Arm: High Digital Media Exposure Cohort
    Participants with elevated exposure to financial news, algorithmic media feeds, social media platforms, and information-intensive digital environments associated with financial and geopolitical stress signaling.

Primary Outcome Measure

Change in Heart Rate Variability (HRV) During Financial Stress Exposure [ Time Frame: Baseline through 24 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIP
Truway Health, Inc.New YorkNew York10016

Find similar trials in New York, NY

By condition
Insomnia
By specialty
Mental healthSleep medicine
By research site
Truway Health, Inc.· New York, NY

Related Studies